Fintech PR
Core Sustainability Capital and Fidelis New Energy announce investment partnership in the Norne Carbon Storage Hub enabling safe, permanent, and economical CO2 storage in Denmark
COPENHAGEN, Denmark, Jan. 26, 2024 /PRNewswire/ — Core Sustainability Capital (“CS Capital”), backed by the Danish pension fund Velliv, has closed on an investment in the Norne Carbon Storage Hub (“Norne”) with its founder Fidelis New Energy (“Fidelis”). Norne will provide environmentally friendly CO2 transportation and permanent storage to help decarbonize Denmark while providing new high-quality jobs, new tax revenue for Denmark, and new private investment directed to fight the causes of climate change. Norne is a large-scale infrastructure project focused on Carbon Capture and Storage (“CCS”) that commenced engineering, investment, and development efforts in mid-2021 to safely store CO2 by mid-2027. These efforts were driven by Norne’s storage customers and Danish policy aiming to meet a 2027-2028 operations date.
The Norne project has been designated a Project of Common Interest by the European Union (“EU”), recognizing its role as a priority infrastructure project with significant EU impact. Norne is aiming to store over 30 million tons per year of CO2 by 2030. Norne is engaged with several preeminent CO2 customers in Denmark and Europe that plan to start operating their CO2 capture projects by 2028 to meet internal and EU deadlines.
The investment in Norne is aligned with CS Capital’s investment strategy focused on climate impact companies and projects that support the green transition. Furthermore, the investment builds on the objective of supporting the decarbonization of hard-to-abate industries such as chemicals, district heating plants, and cement production. This aligns with CS Capital’s ambitions and Danish and international strategies to promote and enable the green transition in industries where reducing carbon footprints is the most challenging.
By partnering with Fidelis and investing in and supporting the construction of Norne, CS Capital will address a major climate challenge. The EU estimates that CCS in Europe will grow to 50 million tons of CO2 stored annually in 2030 and 550 million tons of CO2 stored annually in 2050. The EU has concluded that the 2050 CO2 storage target is essential for the EU to reach its net zero target. To support the development of CCS, the EU has implemented an EU-wide legally binding target to capture 50 million tons of CO2 annually in 2030. The legally binding commitment is underpinned by significant subsidies across the EU for CCS.
“We are proud to invest in Norne and to enter into this partnership with Fidelis. Norne plays a vital role for the green transition and is critical for the Danish and European decarbonization goals. Once fully constructed, Norne will be able to capture CO2 amounts corresponding to over half of the yearly total CO2 emissions of Denmark. Through the impact investment in Norne, we look forward to supporting the decarbonization of hard-to-abate industries, one of the investment goals of CS Capital,” says Per Frederiksen, Managing Partner in CS Capital.
Velliv’s CIO, Anders Stensbøl Chistiansen, said, “Velliv has a strategy to invest in companies that, through innovative solutions, contribute to achieving the goals of the Paris Agreement while ensuring attractive returns for our customers. The investment in Norne through Core Sustainability Fund I is a testament to this strategy, and we look forward to collaborating with Core Sustainability Capital and Fidelis on this attractive investment.”
“We are excited to have Core Sustainability Capital together with Velliv as a key partner in the Norne Carbon Storage Hub. Norne is a strategic Danish project enabling safe and effective carbon reduction of Danish and European economies while maintaining global competitiveness”, says Daniel J. Shapiro, Fidelis CEO. “We look forward to continuing our partnership with Per and Carsten at Core Sustainability Capital as we work to help Denmark become a leader in carbon storage,” says Bengt Jarlsjo, Fidelis President and COO. Ulrik Weuder, Managing Director of Fidelis New Energy Europe, added, “Core Sustainability Capital together with Velliv are perfect partners for Norne as they share core values with Fidelis. Norne is supported by strong Danish institutional investors supporting the decarbonization of Denmark at lower costs than what would be possible without the scale and scope of Norne.”
Santander Corporate & Investment Bank acted as sole financial advisor to Norne. Kromann Reumert served as the legal counsel for Norne. Accura acted as advisor to Core Sustainability Capital
About Core Sustainability Capital
Core Sustainability Capital (“CS Capital”) is a private capital investment manager, investing in Nordic companies with strong sustainable and impact purposes. CS Capital manages DKK 5 billion in its Core Sustainability Fund I, which is backed by the Danish pension fund Velliv. CS Capital is an active investor with a focus on equity minorities and credit investments to support impact companies and projects with their sustainable growth ambitions towards the green transition.
About Velliv
Velliv is one of Denmark’s largest pension companies, with more than 360,000 customers. It has been awarded Best Commercial Pension Fund of the Year in Denmark by FinansWatch and EY in 2018, 2020, 2021, 2022, and 2023.
About Fidelis New Energy
Fidelis New Energy, LLC is an energy transition company driving decarbonization through investments in renewable fuels, low or negative carbon intensity products, and carbon capture and storage in Europe and the United States of America. Fidelis focuses carbon emission reductions by utilizing proven technologies to provide safe innovative solutions with low costs and environmental impacts.
Fidelis New Energy is headquartered in Houston with a European office in Copenhagen, Denmark. Fidelis has a portfolio of patent pending technologies providing climate benefits through the innovative integration of proven technologies. To learn more about Fidelis and its energy transition technologies, including FidelisH2®, H2PowerCool™, and CO2PowerGrow™ please visit www.fidelisnewenergy.com
About the Norne Carbon Storage Hub
The Norne Carbon Storage Hub consists of CO2 reception facilities, pipelines and storage facilities designed to store CO2 safely and permanently. Norne will receive and store CO2 from Danish and European customers. For additional information regarding the Norne Carbon Storage Hub, please visit www.norneccs.com
|
Fidelis New Energy, LLC |
Core Sustainability Capital |
|
+45 92155140 |
|
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News5 days ago
AI-powered Panax raises $15m to reshape cash flow management
-
Latest News5 days ago
Yili’s 2023 Revenue Reaches 126.2 Billion Yuan, Leading Global Dairy Industry towards Healthy and Sustainable Development
-
Latest News5 days ago
“Grand Huangshan” Debuts at the 2024 World Brand Moganshan Conference
-
Latest News5 days ago
Egypt’s Swypex launches an all-in-one fintech platform after $4m seed round
-
Latest News5 days ago
Sweden’s Mitigram names Pedram Tadayon as new CEO
-
Latest News5 days ago
Sobha Developers bring to Singapore an Exclusive Dubai Property Showcase
-
Latest News5 days ago
South African fintech Lesaka snaps up Adumo in $86m deal
-
Latest News5 days ago
India has remained a steady ship in choppy waters says DSP Asset Managers